SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allogene Therapeutics, Inc. – ‘8-K’ for 9/15/22 – ‘XML’

On:  Wednesday, 9/21/22, at 9:05am ET   ·   For:  9/15/22   ·   Accession #:  1737287-22-72   ·   File #:  1-38693

Previous ‘8-K’:  ‘8-K’ on / for 8/9/22   ·   Next:  ‘8-K’ on / for 10/6/22   ·   Latest:  ‘8-K’ on / for 3/14/24   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/21/22  Allogene Therapeutics, Inc.       8-K:8       9/15/22   10:164K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     35K 
 5: R1          Cover                                               HTML     45K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- allo-20220915_htm                   XML     21K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- allo-20220915_lab                     XML     67K 
 4: EX-101.PRE  XBRL Presentations -- allo-20220915_pre              XML     33K 
 2: EX-101.SCH  XBRL Schema -- allo-20220915                         XSD     10K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    16K 
10: ZIP         XBRL Zipped Folder -- 0001737287-22-000072-xbrl      Zip     16K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.22.2.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 1 </ContextCount>
<ElementCount> 22 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 0 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 0 </UnitCount>
<MyReports>
<Report instance="allo-20220915.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 0001001 - Document - Cover </LongName>
<ReportType> Sheet </ReportType>
<Role> http://allogene.com/role/Cover </Role>
<ShortName> Cover </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="8-K" original="allo-20220915.htm"> allo-20220915.htm </File>
<File> allo-20220915.xsd </File>
<File> allo-20220915_lab.xml </File>
<File> allo-20220915_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy items="22"> http://xbrl.sec.gov/dei/2021 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> false </HasCalculationLinkbase>
</FilingSummary>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/02/23  Allogene Therapeutics, Inc.       424B5                  2:542K                                   Donnelley … Solutions/FA
11/02/22  Allogene Therapeutics, Inc.       S-3ASR     11/02/22    9:1.7M
↑Top
Filing Submission 0001737287-22-000072   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 10:58:43.1pm ET